Myxedema Coma Score Calculation and Diagnostic Thresholds
A score of ≥60 on the myxedema coma diagnostic scoring system is diagnostic for myxedema coma, while scores between 45-59 indicate patients at risk who require close monitoring and early intervention. 1
How the Score is Calculated
The myxedema coma score is a semiquantitative diagnostic point scale that evaluates six major clinical domains:
Scoring Components
1. Thermoregulatory Dysfunction (Temperature)
- Hypothermia is a cardinal feature
- Lower temperatures receive higher point values
- Temperature <35.0°C contributes significantly to the score 1, 2
2. Central Nervous System Alterations
- Assessed using Glasgow Coma Scale (GCS)
- Lower GCS scores indicate more severe impairment
- Altered mental status ranging from confusion to coma
- GCS ≤8 indicates severe impairment requiring immediate intervention 2
3. Cardiovascular System Dysfunction
- Bradycardia (heart rate assessment)
- Hypotension
- Lower heart rates contribute more points 2
4. Gastrointestinal System Involvement
- Presence of ileus or constipation
- Ascites
5. Metabolic Derangements
- Thyroid function tests: TSH and free thyroxine (FT4) levels
- Markedly elevated TSH with very low FT4
- Hyponatremia
- Hypoglycemia 1, 2
6. Precipitating Event
- Presence or absence of an identifiable trigger
- Common precipitants include sepsis, cold exposure, medications (sedatives, anesthetics), trauma, or acute illness 1, 3
Score Interpretation and Clinical Action
Score ≥60: Diagnostic for myxedema coma
- Sensitivity: 100%
- Specificity: 85.71%
- Requires immediate ICU admission and aggressive treatment
- Mortality risk is extremely high without prompt intervention 1
Score 45-59: At risk for myxedema coma
- Requires close monitoring in high-dependency setting
- Early intervention may prevent progression
- Consider empiric treatment if clinical deterioration occurs 1
Score <45: Unlikely to represent myxedema coma
- May represent severe hypothyroidism without decompensation
- Standard hypothyroidism management appropriate 1
Prognostic Value
Score >90: Significantly higher mortality (OR 11.8, p=0.026)
Score >110: 100% mortality in one cohort study 3
The myxedema score demonstrated superior predictive power compared to general critical care scores, with an area under the ROC curve of 0.88, making it specifically valuable for this endocrine emergency 1.
Clinical Application
The score enables rapid bedside assessment without waiting for complete laboratory results. Initial scoring can begin with clinical parameters (temperature, heart rate, GCS, precipitating factors) while thyroid function tests are pending. This facilitates earlier recognition and treatment initiation, which is critical given that myxedema coma carries a 25-65% mortality rate even with treatment 2, 3, 4.
Key caveat: The score should not delay treatment in patients with classic clinical features (hypothermia, bradycardia, altered mental status) and known or suspected severe hypothyroidism. When clinical suspicion is high, empiric treatment with stress-dose hydrocortisone followed by thyroid hormone replacement should begin immediately 5, 6.